Printer Friendly

Browse Recombinant DNA topic

 

Articles

1-98 out of 98 article(s)
Title Author Type Date Words
Nature as a totem, "Genetically Modified Organisms" as a contemporary taboo. Tagliabue, Giovanni Report Jun 1, 2016 4444
Trends in United States biological materials oversight and Institutional Biosafety Committees. Jenkins, Chris Mar 22, 2014 12442
Effect of dietary phytase transgenic corn on physiological characteristics and the fate of recombinant plant DNA in laying hens. Gao, Chunqi; Ma, Qiugang; Zhao, Lihong; Zhang, Jianyun; Ji, Cheng Report Jan 1, 2014 4199
16S rDNA-based metagenomic analysis of bacterial diversity associated with two populations of the Kleptoplastic sea slug Elysia chlorotica and its algal prey Vaucheria litorea. Devine, Susan P.; Pelletreau, Karen N.; Rumpho, Mary E. Report Aug 1, 2012 12327
Molecular epidemiology of feline and human Bartonella henselae isolates. Bouchouicha, Rim; Durand, Benoit; Monteil, Martine; Chomel, B.B.; Berrich, Moez; Arvand, Mardjan; Bi May 1, 2009 2774
Production of a his-tag recombinant far protein and analysis of the lifecycle stages of Hp-FAR-1. Bath, Jennifer L.; Kennedy, Malcolm W.; Drees, Jeremy; Maetzold, Erin; Scheidt, Michael; Knox, Megan Abstract Apr 1, 2009 537
Application of 16S rDNA based seminested PCR for diagnosis of acute bacterial meningitis. Chakrabarti, P.; Das, B.K.; Kapil, Arti Clinical report Feb 1, 2009 4180
Emergence of Francisella novicida bacteremia, Thailand. Leelaporn, Amornrut; Yongyod, Samaporn; Limsrivanichakorn, Sunee; Yungyuen, Thitiya; Kiratisin, Patt Dec 1, 2008 1951
Molecular detection of food pathogens from retailed fast food samples by PCR. Parekh, Tarak; Subhash, Rema Clinical report Dec 1, 2008 4049
Immunizing antigens and constituents of vaccines/Bagisiklik antijenleri ve asi icerigi. Keser, Melike; Hatipoglu, Nevin Sep 1, 2008 5836
Morphology and gene analysis of hybrids between two congeneric sea stars with different modes of development. Wakabayashi, Kaori; Komatsu, Mieko; Murakami, Manabu; Hori, Isao; Takegami, Tsutomu Report Aug 1, 2008 5339
Identification of larval sea basses (Centropristis spp.) using ribosomal DNA-specific molecular assays. Vandersea, Mark W.; Litaker, R. Wayne; Marancik, Katrin E.; Hare, Jonathan A.; Walsh, Harvey J.; Lem Report Apr 1, 2008 6767
Tercica Initiates Phase II Clinical Trial with Next-Generation Growth Hormone Product for the Treatment of Short Stature. Jan 22, 2008 814
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute obtains United States patent. Jan 1, 2008 136
FDA Approval of easypod(R): New Electronic Growth Hormone Injection Device. Nov 8, 2007 829
Hollis-Eden Pharmaceuticals Commencing Phase I/II Clinical Trial with TRIOLEX(TM) (HE3286) in Obese, Insulin Resistant Volunteers. Oct 16, 2007 1138
Paratus Delivers Medicines to War-Ravaged Kirkuk. Oct 9, 2007 592
High Growth Forecasted in the External Insulin Pumps Industry. Oct 2, 2007 351
Millipore and Novo Nordisk expand agreement to supply recombinant human insulin. Sep 1, 2007 378
Efficient deletion of transgenic DNA from complex integration locus of rice mediated by Cre/lox recombination system. Moore, Sarah K.; Srivastava, Vibha Mar 1, 2006 5029
Agricultural biotechnology: overregulated and underappreciated; The pursuit of an integrated action plan, including regulatory reform, will help the United States and the world reap enormous benefits that now are thwarted. Miller, Henry I.; Conko, Gregory Jan 1, 2005 2969
Invasive genes: humans incorporate DNA from parasite. Lock, C. Jul 31, 2004 526
Say cheese! Chymosin was the first food product of genetic engineering. Schwarcz, Joe May 1, 2004 1013
Rockefeller University obtains United States patent. Brief Article Apr 1, 2004 165
Suntory obtains United States patent. Brief Article Apr 1, 2004 81
Symphogen obtains European patent for methods to produce recombinant polyclonal antibodies. Jun 1, 2003 471
Iron-dependent hydrogenases of Entamoeba histolytica and Giardia lamblia: activity of the recombinant entamoebic enzyme and evidence for lateral gene transfer. Nixon, Julie E.J.; Field, Jessica; McArthur, Andrew G.; Sogin, Mitchell L.; Yarlett, Nigel; Loftus, Feb 1, 2003 5113
Validation of a recombinant DNA construct ([micro]LCR and full-length [beta]-globin gene) for quantification of human [beta]-globin expression: application to mutations in the promoter, intronic, and 5'- and 3'-untranslated regions of the human [beta]-globin gene. Irenge, Leonid M.; Heusterspreute, Michel; Philippe, Marianne; Derclaye, Isabelle; Robert, Annie; Ga Oct 1, 2002 3432
Ambion licenses RNA interference technology from MIT. Brief Article Mar 1, 2002 226
NEW INSULIN ANALOGUE. Tucker, Miriam E. Jul 1, 2001 135
A COLLABORATIVE RECOMBINANT DNA TECHNOLOGY COURSE WITH LABORATORY. Brief Article Apr 1, 2001 178
Whatman Purchases Invitrogen Business. Feb 28, 2001 90
Patent awarded to Biomed for homeopathic recombinant human growth hormone. Feb 1, 2001 313
Transkaryotic receives patent for gene targeting technology. Feb 1, 2001 369
Estonian parliament passes law creating world's largest gene bank. Brief Article Jan 16, 2001 184
Akkadix acquires exclusive license to Pangene's enhanced homologous recombination technologies for plant science applications. Brief Article Sep 1, 2000 663
Japan to conditionally patent DNA fragments. Oct 11, 1999 348
Principia Pharmaceutical formed to develop therapeutic proteins with prolonged activity. Aug 1, 1999 442
Phytomedics announces allowance of a United States patent for transgenic plant recombinant protein technology. Jun 1, 1999 385
Limagrain Genetics Corp. Announces Its Intention to Cash Out the Public Stockholders of BioTechnica International, Inc. Sep 21, 1998 358
Genetic MicroSystems Inc. and Takara Shuzo Co., Ltd. Sign Distribution Agreement For DNA Microarray Products. Article Sep 10, 1998 328
Human Medical Options (Latin America) S.A. Panama Makes Announcement. Article Aug 25, 1998 333
CSI Researchers Express ssDNA in HeLa Cells. Article Aug 4, 1998 111
Agennix Receives U.S. Patent On Production of Recombinant Lactoferrin. Article Jul 13, 1998 267
CSI Researchers Express ssDNA in Vivo. Article Jul 6, 1998 182
Pharmaceutical firms and the transition to biotechnology: a study in strategic innovation. Galambos, Louis; Sturchio, Jeffrey L. Jun 22, 1998 12488
Lynx to Use New Technology for Polymorphism Searches and Genotyping. Article Jun 16, 1998 233
Recombination values for the Ms6-W1 chromosome region in different genetic backgrounds in soybean. Palmer, R.G.; Holland, J.B.; Lewers, K.S. Mar 1, 1998 3328
DowElanco, SemBioSys Ally to Pursue Molecular Farming Dec 1, 1997 288
Organon Receives U.S. FDA Clearance to Market FOLLISTIM(TM); First Recombinant Infertility Treatment Available in the U.S. Sep 30, 1997 754
Hyseq Announces Second Quarter Results Sep 12, 1997 691
Chromos and Pharming Form Strategic Transgenics Alliance Sep 10, 1997 613
Aastrom Biosciences, Inc. Reports Fourth Quarter and Fiscal 1997 Financial Results Sep 5, 1997 948
Schering-Plough Submits BLA for INTRON(R) A Pediatric Use in Chronic Hepatitis B Sep 4, 1997 330
Ares-Serono and Bio-Technology General (BTG) Sign License Agreement Sep 3, 1997 783
Molecular biological methods in diagnosis and treatment of liver diseases. Worman, Howard J. Aug 1, 1997 8749
Hyland Division of Baxter Takes Precautionary Action With Recombinant Factor VIII Therapy Jul 13, 1997 359
Viragen Hires Schering-Plough Interferon Specialist Jun 26, 1997 299
ICOS Corp. announces Phase 2 clinical trial with human recombinant PAF-AH. Jun 20, 1997 211
FDA clears Genentech's Nutropin AQ for use in Turner Syndrome Patients. Apr 1, 1997 284
The Ares-Serono Group Reports Results for 1996 and Increased Dividend Proposal Mar 17, 1997 1738
Protein Sciences Corporation appoints Dr. Bethanie E. Wilkinson Director, Business Development. Feb 25, 1997 249
Covance begins manufacturing at biotech facility. Jan 29, 1997 355
Somatogen announces second quarter results. Jan 17, 1997 348
IDEC Pharmaceuticals Grants Boehringer Ingelheim GmbH License to Technology for High Yield Protein Expression Jan 16, 1997 448
Stadtlanders Pharmacy Chosen For Distribution Of Serostim Jan 13, 1997 435
Francois Lebel, M.D., FRCPC joins GalaGen as Vice President of Scientific and Regulatory Affairs. Jan 8, 1997 452
Novo Nordisk Cleared to Market Human Growth Hormone - Appeals Court Stays Preliminary Injunction - Dec 20, 1996 353
Serono Laboratories Launches Serostim, Human Growth Hormone (rDNA Origin), for the Treatment of AIDS Wasting Dec 2, 1996 1445
Trinity Biotech Signs License Agreement with Imperial College London Nov 21, 1996 458
Genetics Institute's Recombinant Factor IX Scheduled for FDA Advisory Committee Review Nov 20, 1996 262
Novopharm Biotech Announces New Opportunities for Recombinant NOVOMAb-G2. Nov 13, 1996 333
Somatogen announces first quarter results. Oct 17, 1996 307
Pharmacia & Upjohn Settles Litigation with Biogen Sep 30, 1996 272
Somatogen files IND for recombinant hemoglobin as treatment for anemia. Feb 20, 1996 229
Convergence in the feeding apparatuses of lophophorates and pterobranch hemichordates revealed by 18S rDNA: an interpretation. Halanych, Kenneth M. Feb 1, 1996 3352
FDA grants Genentech clearance to market Nutropin AQ. Jan 3, 1996 125
Spinal Markets To Grow at 7 Percent Rate, Top $300 Million, Slowed By Regulatory, Legal Worries. Jan 2, 1996 517
GENETICS INSTITUTE COMPLETES ACQUISITION OF SCIGENICS, INC. Dec 7, 1995 376
Astra Merck Inc. and Lexin Pharmaceutical Corporation announce agreement to test acute pancreatitis therapy; Astra Merck agrees to fund development. Oct 30, 1995 660
Connective Therapeutics Completes Phase I Safety Trial of Relaxin for Scleroderma. Aug 24, 1995 480
Bio-Technology General plans to appeal preliminary injunction in U.S. Court of Appeals. Aug 11, 1995 282
Serono sponsors clinical trial to study safety and efficacy of mammalian cell-derived recombinant human growth hormone (r-hGH(m)) in children with HIV-associated "failure to thrive". Mar 29, 1995 384
GENENTECH LICENSES IDEC PHARMACEUTICALS' TECHNOLOGY FOR HIGH-LEVEL GENE EXPRESSION Mar 16, 1995 550
GENETICS INSTITUTE BEGINS CLINICAL TRIAL OF rhFACTOR IX Feb 27, 1995 729
SOFAMOR DANEK AND GENETICS INSTITUTE ENTER INTO CORPORATE ARRANGEMENTS FOR COMMERCIALIZING BONE MORPHOGENETIC PROTEIN IN SPINAL RECONSTRUCTION. Feb 17, 1995 573
NEUPOGEN (R) approved in Europe for peripheral cell support. Jan 12, 1995 483
GENVEC, LEADING GENE THERAPY COMPANY, HAS CLINICAL TRIAL APPROVED BY NATIONAL INSTITUTES OF HEALTH FOR REPEAT DOSING OF CYSTIC FIBROSIS THERAPY Sep 20, 1994 673
ONCOGENE SCIENCE, INC. REPORTS WOUND HEALING DATA Aug 30, 1994 394
ARMOUR TO INTRODUCE SECOND RECOMBINANT FACTOR VIII PRODUCT WORLDWIDE May 5, 1994 341
THOMAS A. BOLOGNA JOINS SCRIPTECH PHARMACEUTICALS, INC. AS PRESIDENT AND CHIEF EXECUTIVE OFFICER Jan 30, 1994 295
Recombinant DNA. Asimov, Isaac Reference Source Jan 1, 1994 110
AFFYMAX AWARDED FIRST U.S. PATENT FOR RECOMBINANT PEPTIDE DIVERSITY TECHNOLOGY Dec 28, 1993 467
Genes may shuffle in developing brain. Ezzell, Carol Oct 5, 1991 607
Recombinant rodents, human hemoglobin. Weiss, R. Sep 2, 1989 543
Battling illness with body proteins; recombinant DNA technology has enabled medical researchers to manufacture several human proteins that can bolster the body's natural defenses against disease. Murray, Mary Jan 17, 1987 2702
Mummy DNA intact after 2,400 years. Miller, Julie Ann Apr 27, 1985 407
Lessons from Asilomar; ten years after the historic conference on the risks of gene-splicing research, scientists look back with a mixture of pride, disappointment and embarrassment. Miller, Julie Ann Feb 23, 1985 2326

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters